Abstract | OBJECTIVE: METHOD: An open cohort study included all consecutively discharged patients with schizophrenia in a 3-year period (n=277). The treatment-dependent variables were entered in a multivariate Cox survival analyses with time to unplanned readmission as the dependent variable. RESULTS: 11.2% of patients were readmitted within 30 days of discharge, and 44.8% were readmitted within 12 months. Antipsychotic monotherapy reduced the risk of readmission by 74.9%. Treatment in CMHC also had a risk-reducing effect. The prescription rate of clozapine in this sample was 10.1%. DISCUSSION: CONCLUSIONS:
|
Authors | R A Kroken, L S Mellesdal, T Wentzel-Larsen, H A Jørgensen, E Johnsen |
Journal | European psychiatry : the journal of the Association of European Psychiatrists
(Eur Psychiatry)
Vol. 27
Issue 7
Pg. 489-95
(Oct 2012)
ISSN: 1778-3585 [Electronic] England |
PMID | 21683554
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier Masson SAS. All rights reserved. |
Chemical References |
|
Topics |
- Adult
- Antipsychotic Agents
(therapeutic use)
- Cohort Studies
- Female
- Humans
- Male
- Middle Aged
- Patient Discharge
- Patient Readmission
- Psychotic Disorders
(drug therapy)
- Risk Factors
- Schizophrenia
(drug therapy)
- Treatment Outcome
|